[Federal Register Volume 69, Number 237 (Friday, December 10, 2004)]
[Notices]
[Page 71851]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-27068]



[[Page 71851]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of the National Cooperation Research and Production Act 
of 1993--National Committee for Clinical Laboratory Standards

    Notice is hereby given that, on September 16, 2004, pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), National Committee for 
Clinical Laboratory Standards (``NCCLS'') has filed written 
notifications simultaneously with the Attorney General and the Federal 
Trade Commission disclosing (1) the name and principal place of 
business of the standards development organization and (2) the nature 
and scope of its standards development activities. The notifications 
were filed for the purpose of invoking the Act's provisions limiting 
the recovery of antitrust plaintiffs to actual damages under specified 
circumstances.
    Pursuant to section 6(b) of the Act, the name and principal place 
of business of the standards development organization is: National 
Committee for Clinical Laboratory Standards, Wayne, PA. (On January 1, 
2005 the organization's name will become: Clinical and Laboratory 
Standards Institute). The nature and scope of NCCLS's standards 
development activities are: to improve the quality of work performed by 
organizations concerned with health care services, medical testing, and 
clinical and other laboratory services. Examples include training 
verification; safety of healthcare workers; preanalytic specimen 
collection and handling; evaluation of analytical methods and devices; 
analytic procedures in clinical chemistry and toxicology, hematology, 
immunology and ligand assay, microbiology, and molecular methods; 
performance goals for internal quality control; point of service 
testing in acute and chronic care facilities; physician's office 
laboratory testing; cytologic specimen collection and cytoprepatory 
techniques; laboratory design; laboratory automation and informatics; 
and emergency response procedures.

Dorothy B. Fountain,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 04-27068 Filed 12-9-04; 8:45 am]
BILLING CODE 4410-11-M